Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Irum Khan"'
Autor:
Ivy Abraham, Garth Rauscher, Anand Ashwin Patel, Sarah Monick, Madelyn Burkhart, Eshana Shah, Ami Dave, Matthew Kroll, Stephanie B. Tsai, Stephanie Berg, Amani Erra, Vedavyas Gannamani, Maryam Zia, Melissa L. Larson, Wendy Stock, Jessica K. Altman, Irum Khan
Publikováno v:
Blood. 140:6061-6063
Autor:
Ivy Elizabeth Abraham, Garth H. Rauscher, Anand Ashwin Patel, William B. Pearse, Priya Rajakumar, Madelyn Burkart, Ahmed Aleem, Ami Dave, Sushma Bharadwaj, Koosha Paydary, Maria Acevedo-Mendez, Krishna Goparaju, Richard Gomez, Kylie Carlson, Stephanie B. Tsai, John G. Quigley, John P. Galvin, Maryam Zia, Melissa L. Larson, Stephanie Berg, Wendy Stock, Jessica K. Altman, Irum Khan
Publikováno v:
Blood. 139:2212-2226
Non-Hispanic Black (NHB) and Hispanic patients with acute myeloid leukemia (AML) have higher mortality rates than non-Hispanic White (NHW) patients despite more favorable genetics and younger age. A discrete survival analysis was performed on 822 adu
Autor:
Irum Khan, Andrei L. Gartel
Publikováno v:
Blood Advances. 6:4028-4030
Autor:
Samin Houshyar, Betul Gok Yavuz, Pritesh Patel, Nadim Mahmud, Karen Sweiss, Irum Khan, Santosh L. Saraf, Damiano Rondelli, Anwar Khan, John G. Quigley
Publikováno v:
Blood. 140:5957-5958
Autor:
Ana Maria Avila, Saad Arain, Karen Sweiss, Pritesh Patel, Samin Houshyar, Gregory S Calip, Irum Khan, Paul G. Rubinstein, Chukwuemeka Uzoka, John G. Quigley
Publikováno v:
Blood. 140:11774-11775
Autor:
Irum Khan, Nepheli Raptis, Wendy Stock, Melissa L. Larson, Stephanie Berg, Shira Dinner, Ami Dave, Anand Patel, Jessica K. Altman, Ivy Abraham, Garth H. Rauscher, William B Pearse, Maryam Zia, Madelyn Burkart
Publikováno v:
Blood. 138:844-844
Introduction AYA cancer patients (pts) face unique healthcare disparities due to their social development stage. AYA with AML and minorities continue to suffer reduced survival (Kahn, Cancer, 2016). Our group demonstrated that structural violence, sp
Autor:
Taha Y. Taha, Irum Khan, Dolores Mahmud, Rajeev Ranjan, Amal Mechaal, Amudha Ganapathy, Pavel A. Petukhov, Nadim Mahmud
Publikováno v:
Blood. 138:2944-2944
The treatment outcomes for patients diagnosed with acute myeloid leukemia (AML) are still dismal. Recent advances in understanding AML indicate that the lack of efficacy is primarily due to non-specificity of currently used chemotherapeutics targetin
Autor:
Pritesh R. Patel, Gregory S. Calip, Betul Gok Yavuz, Eshana E. Shah, Saad Arain, John G. Quigley, Irum Khan, Sarah Stettner
Publikováno v:
Blood. 136:39-40
Background Presently, acute myeloid leukemia (AML) risk stratification is estimated prior to treatment by incorporating patient and disease characteristics. However, apart from the limited use of minimal residual disease measurement, few methodologie
Autor:
Richard Gomez, William Pearse, Melissa C. Larson, John G. Quigley, Stephanie B. Tsai, Garth H. Rauscher, Irum Khan, Anand Patel, Sushma Bharadwaj, Jessica K. Altman, Wendy Stock, Ivy Abraham, Kylie Carlson, Stephanie Berg, Ami Dave, Maryam Zia, Priya Rajakumar, Ahmed Aleem, Maria Acevedo-Mendez, Koosha Paydary
Publikováno v:
Blood. 136:10-10
Background: Non-Hispanic Black (NHB) and Hispanic patients with Acute Myeloid Leukemia (AML) have higher mortality rates than non-Hispanic white (NHW) patients despite lower incidence, more favorable genetics, and a younger age at presentation (Darbi
Autor:
John G. Quigley, Ivy Abraham, Irum Khan, Anand Patel, Maryam Zia, Priya Rajakumar, Maria Acevedo-Mendez, William Pearse, Jessica K. Altman, Wendy Stock, Melissa L. Larson, Koosha Paydary, John P. Galvin, Sushma Bharadwaj, Garth H. Rauscher
Publikováno v:
Blood. 134:3413-3413
Background: Non-Hispanic Black (NHB) and Hispanic patients with Acute Myeloid Leukemia (AML) have higher mortality rates than non-Hispanic white (NHW) patients despite a lower incidence of disease, more favorable genetics and younger age at presentat